Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...

UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...

Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

The FTC, led by chair Lina Khan, is seeking to ultimately lower insurance premiums as well as wholesale prices, which in the ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...

The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...

The suit accuses the "Big Three" of steering diabetes patients toward high-priced insulin to benefit their bottom lines ...